NIH R01 · 2025
Microneedle patch delivery of replication-inducible monkeypox vaccine
ABSTRACT Monkeypox virus (MPXV) was declared a global health emergency of international concern with over 96,000 cases globally in 117 countries. Various nations, including the USA, UK, and Canada, have implemented a "ring vaccination" strategy to curb MPXV spread, a selective vaccination approach successful in containing smallpox and Ebola outbreaks. The Centers for Disease Control and Prevention (CDC) recommends vaccination for individuals at high risk of MPXV infection. However, there is currently no vaccine specifically developed against MPXV. Smallpox vaccines, assumed to be 85% effective and providing cross-protective immunity, are recommended by the WHO and CDC. Despite minimal…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.